这是一篇来自已证抗体库的有关大鼠 Ifng的综述，是根据36篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合Ifng 抗体。
Ifng 同义词: IFNG2; interferon gamma; IFN-gamma

赛默飞世尔
小鼠 单克隆（DB-1 (DB1)）
  • 流式细胞仪; 大鼠; 图 s6e
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于流式细胞仪在大鼠样品上 (图 s6e). Proc Natl Acad Sci U S A (2016) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 图 4b
赛默飞世尔 Ifng抗体（eBioscience, DB1)被用于被用于酶联免疫吸附测定在大鼠样品上 (图 4b). Brain Behav Immun (2015) ncbi
山羊 多克隆
  • 免疫印迹; 大鼠; 1:500
  • 免疫组化; 小鼠; 1:100
赛默飞世尔 Ifng抗体（Thermo Scientific, PA1-24782)被用于被用于免疫印迹在大鼠样品上浓度为1:500 和 被用于免疫组化在小鼠样品上浓度为1:100. J Cell Commun Signal (2015) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 免疫组化; 大鼠
赛默飞世尔 Ifng抗体（Invitrogen, ARC4033)被用于被用于免疫组化在大鼠样品上. Exp Neurol (2015) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 图 5
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上 (图 5). Clin Exp Immunol (2006) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 小鼠; 图 4
赛默飞世尔 Ifng抗体（Biosource, DB1)被用于被用于酶联免疫吸附测定在小鼠样品上 (图 4). Parasitol Res (2005) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 图 5
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上 (图 5). Inflamm Bowel Dis (2005) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上. Immunology (2005) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 1 ug/ml
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上浓度为1 ug/ml. Immunol Lett (2005) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 10 ug/ml; 图 4
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上浓度为10 ug/ml (图 4). Neuroscience (2004) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 图 3
赛默飞世尔 Ifng抗体（BioSource, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上 (图 3). J Immunol (2004) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 小鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在小鼠样品上. J Autoimmun (2004) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 图 3
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上 (图 3). Clin Exp Immunol (2004) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 抑制或激活实验; 大鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于抑制或激活实验在大鼠样品上. J Immunol Methods (2003) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 免疫组化-冰冻切片; 小鼠
赛默飞世尔 Ifng抗体（BioSource International, clone DB-1)被用于被用于免疫组化-冰冻切片在小鼠样品上. J Neuroimmunol (2002) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 抑制或激活实验; 大鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于抑制或激活实验在大鼠样品上. Pediatr Res (2002) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 10 ug/ml; 图 2
赛默飞世尔 Ifng抗体（Biosource, clone DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上浓度为10 ug/ml (图 2). Am J Respir Cell Mol Biol (2002) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 流式细胞仪; 大鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于流式细胞仪在大鼠样品上. J Gastroenterol Hepatol (2002) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 图 8
赛默飞世尔 Ifng抗体（BioSource International, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上 (图 8). J Immunol (2001) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 小鼠; 图 1
赛默飞世尔 Ifng抗体（BioSource International, DB-1)被用于被用于酶联免疫吸附测定在小鼠样品上 (图 1). J Immunol (2001) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 流式细胞仪; 大鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于流式细胞仪在大鼠样品上. J Immunol Methods (2000) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 免疫组化-石蜡切片; 大鼠; 图 6
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于免疫组化-石蜡切片在大鼠样品上 (图 6). J Immunol (2000) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠; 2 ug/ml; 图 1
赛默飞世尔 Ifng抗体（BioSource International, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上浓度为2 ug/ml (图 1). J Immunol (1999) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 大鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在大鼠样品上. Infect Immun (1999) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 免疫组化-石蜡切片; 大鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于免疫组化-石蜡切片在大鼠样品上. J Immunol (1999) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 免疫组化; 大鼠
赛默飞世尔 Ifng抗体（biosource, DB-1)被用于被用于免疫组化在大鼠样品上. Transplantation (1998) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 小鼠; 图 1
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在小鼠样品上 (图 1). J Immunol (1997) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 酶联免疫吸附测定; 小鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于酶联免疫吸附测定在小鼠样品上. Infect Immun (1997) ncbi
小鼠 单克隆（DB-1 (DB1)）
  • 抑制或激活实验; 小鼠
赛默飞世尔 Ifng抗体（Biosource, DB-1)被用于被用于抑制或激活实验在小鼠样品上. Infect Immun (1995) ncbi
BioLegend
小鼠 单克隆（DB-1）
  • 流式细胞仪; 大鼠; 图 s4b
BioLegend Ifng抗体（Biolegend, DB-1)被用于被用于流式细胞仪在大鼠样品上 (图 s4b). Nature (2019) ncbi
小鼠 单克隆（DB-1）
  • 流式细胞仪; 大鼠; 图 4c
BioLegend Ifng抗体（BioLegend, DB-1)被用于被用于流式细胞仪在大鼠样品上 (图 4c). Eur J Immunol (2017) ncbi
小鼠 单克隆（DB-1）
  • 免疫印迹; 大鼠
BioLegend Ifng抗体（Biolegend, 507802)被用于被用于免疫印迹在大鼠样品上. Int J Clin Exp Pathol (2015) ncbi
小鼠 单克隆（DB-1）
BioLegend Ifng抗体（BioLegend, DB-1)被用于. J Immunol (2014) ncbi
艾博抗（上海）贸易有限公司
兔 单克隆（EPR1108）
  • 免疫细胞化学; 小鼠; 1:200; 图 3e
艾博抗（上海）贸易有限公司 Ifng抗体（Abcam, ab133566)被用于被用于免疫细胞化学在小鼠样品上浓度为1:200 (图 3e). Nat Commun (2016) ncbi
圣克鲁斯生物技术
小鼠 单克隆（DB-14）
  • 免疫印迹; 小鼠; 1:1000; 图 3
圣克鲁斯生物技术 Ifng抗体（Santa Cruz Biotechnology, sc-59992)被用于被用于免疫印迹在小鼠样品上浓度为1:1000 (图 3). Sci Rep (2015) ncbi
小鼠 单克隆（DB-14）
  • 免疫印迹; 小鼠; 图 5
圣克鲁斯生物技术 Ifng抗体（Santa Cruz, sc-59992)被用于被用于免疫印迹在小鼠样品上 (图 5). Laryngoscope (2014) ncbi
文章列表
  1. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed 出版商
  2. Tuncel J, Haag S, Holmdahl R. MHC class II alleles associated with Th1 rather than Th17 type immunity drive the onset of early arthritis in a rat model of rheumatoid arthritis. Eur J Immunol. 2017;47:563-574 pubmed 出版商
  3. Wu X, Wu X, Ma Y, Shao F, Tan Y, Tan T, et al. CUG-binding protein 1 regulates HSC activation and liver fibrogenesis. Nat Commun. 2016;7:13498 pubmed 出版商
  4. Flach A, Litke T, Strauss J, Haberl M, Gómez C, Reindl M, et al. Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. Proc Natl Acad Sci U S A. 2016;113:3323-8 pubmed 出版商
  5. Fiume G, Scialdone A, Albano F, Rossi A, Tuccillo F, Rea D, et al. Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice. Sci Rep. 2015;5:13864 pubmed 出版商
  6. Garcia P, Apolinário L, Böckelmann P, da Silva Nunes I, Duran N, Fávaro W. Alterations in ubiquitin ligase Siah-2 and its corepressor N-CoR after P-MAPA immunotherapy and anti-androgen therapy: new therapeutic opportunities for non-muscle invasive bladder cancer. Int J Clin Exp Pathol. 2015;8:4427-43 pubmed
  7. Nacka Aleksić M, Djikić J, Pilipović I, Stojić Vukanić Z, Kosec D, Bufan B, et al. Male rats develop more severe experimental autoimmune encephalomyelitis than female rats: sexual dimorphism and diergism at the spinal cord level. Brain Behav Immun. 2015;49:101-18 pubmed 出版商
  8. Fisher P, Zhao Y, Rico M, Massicotte V, WADE C, Litvin J, et al. Increased CCN2, substance P and tissue fibrosis are associated with sensorimotor declines in a rat model of repetitive overuse injury. J Cell Commun Signal. 2015;9:37-54 pubmed 出版商
  9. Pusic A, Mitchell H, Kunkler P, Klauer N, Kraig R. Spreading depression transiently disrupts myelin via interferon-gamma signaling. Exp Neurol. 2015;264:43-54 pubmed 出版商
  10. Kim B, Park H, Shin J, Kim S, Kim S. Human placental extract reduces allergic inflammation in a murine allergic rhinitis model. Laryngoscope. 2014;124:E399-404 pubmed 出版商
  11. Chao G, Wallis R, Marandi L, Ning T, Sarmiento J, Paterson A, et al. Iddm30 controls pancreatic expression of Ccl11 (Eotaxin) and the Th1/Th2 balance within the insulitic lesions. J Immunol. 2014;192:3645-53 pubmed 出版商
  12. Hoentjen F, Tonkonogy S, Liu B, Sartor R, Taurog J, Dieleman L. Adoptive transfer of nontransgenic mesenteric lymph node cells induces colitis in athymic HLA-B27 transgenic nude rats. Clin Exp Immunol. 2006;143:474-83 pubmed
  13. Al Qaoud K, Abdel Hafez S. Humoral and cytokine response during protection of mice against secondary hydatidosis caused by Echinococcus granulosus. Parasitol Res. 2005;98:54-60 pubmed
  14. Hoentjen F, Welling G, Harmsen H, Zhang X, Snart J, Tannock G, et al. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis. 2005;11:977-85 pubmed
  15. Qian B, Tonkonogy S, Hoentjen F, Dieleman L, Sartor R. Dysregulated luminal bacterial antigen-specific T-cell responses and antigen-presenting cell function in HLA-B27 transgenic rats with chronic colitis. Immunology. 2005;116:112-21 pubmed
  16. Janelidze S, Enell K, Visse E, Darabi A, Salford L, Siesjo P. Activation of purified allogeneic CD4(+) T cells by rat bone marrow-derived dendritic cells induces concurrent secretion of IFN-gamma, IL-4, and IL-10. Immunol Lett. 2005;101:193-201 pubmed
  17. Moalem G, Xu K, Yu L. T lymphocytes play a role in neuropathic pain following peripheral nerve injury in rats. Neuroscience. 2004;129:767-77 pubmed
  18. Todd D, Forsberg E, Greiner D, Mordes J, Rossini A, Bortell R. Deficiencies in gut NK cell number and function precede diabetes onset in BB rats. J Immunol. 2004;172:5356-62 pubmed
  19. Cabarrocas J, Piaggio E, Zappulla J, Desbois S, Mars L, Lassmann H, et al. A transgenic mouse model for T-cell ignorance of a glial autoantigen. J Autoimmun. 2004;22:179-89 pubmed
  20. Dieleman L, Hoentjen F, Qian B, Sprengers D, Tjwa E, Torres M, et al. Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin Exp Immunol. 2004;136:30-9 pubmed
  21. Chakir H, Wang H, Lefebvre D, Webb J, Scott F. T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: predominant role of GATA-3. J Immunol Methods. 2003;278:157-69 pubmed
  22. Archin N, Atherton S. Infiltration of T-lymphocytes in the brain after anterior chamber inoculation of a neurovirulent and neuroinvasive strain of HSV-1. J Neuroimmunol. 2002;130:117-27 pubmed
  23. Sorkness R, Castleman W, Mikus L, Mosser A, Lemanske R. Chronic postbronchiolitis airway instability induced with anti-IFN-gamma antibody in F344 rats. Pediatr Res. 2002;52:382-6 pubmed
  24. Hylkema M, Timens W, Luinge M, Van Der Werf N, Hoekstra M. The effect of bacillus Calmette-Guérin immunization depends on the genetic predisposition to Th2-type responsiveness. Am J Respir Cell Mol Biol. 2002;27:244-9 pubmed
  25. Uehara K, Ichida T, Sugahara S, Ishikawa T, Yamagiwa S, Yoshida Y, et al. Systemic administration of liposome-encapsulated OK-432 prolongs the survival of rats with hepatocellular carcinoma through the induction of IFN-gamma-producing hepatic lymphocytes. J Gastroenterol Hepatol. 2002;17:81-90 pubmed
  26. Todd D, Greiner D, Rossini A, Mordes J, Bortell R. An atypical population of NK cells that spontaneously secrete IFN-gamma and IL-4 is present in the intraepithelial lymphoid compartment of the rat. J Immunol. 2001;167:3600-9 pubmed
  27. Liva S, Voskuhl R. Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production. J Immunol. 2001;167:2060-7 pubmed
  28. Caraher E, Parenteau M, Gruber H, Scott F. Flow cytometric analysis of intracellular IFN-gamma, IL-4 and IL-10 in CD3(+)4(+) T-cells from rat spleen. J Immunol Methods. 2000;244:29-40 pubmed
  29. Lin Y, Soares M, Sato K, Csizmadia E, Robson S, Smith N, et al. Long-term survival of hamster hearts in presensitized rats. J Immunol. 2000;164:4883-92 pubmed
  30. Kawai T, Seki M, Hiromatsu K, Eastcott J, Watts G, Sugai M, et al. Selective diapedesis of Th1 cells induced by endothelial cell RANTES. J Immunol. 1999;163:3269-78 pubmed
  31. Cetre C, Pierrot C, Cocude C, Lafitte S, Capron A, Capron M, et al. Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host. Infect Immun. 1999;67:2713-9 pubmed
  32. Lin Y, Soares M, Sato K, Takigami K, Csizmadia E, Anrather J, et al. Rejection of cardiac xenografts by CD4+ or CD8+ T cells. J Immunol. 1999;162:1206-14 pubmed
  33. Miyatake T, Koyamada N, Hancock W, Soares M, Bach F. Survival of accommodated cardiac xenografts upon retransplantation into cyclosporine-treated recipients. Transplantation. 1998;65:1563-9 pubmed
  34. Shibata Y, Metzger W, Myrvik Q. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production. J Immunol. 1997;159:2462-7 pubmed
  35. Shibata Y, Foster L, Metzger W, Myrvik Q. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect Immun. 1997;65:1734-41 pubmed
  36. Früh R, Blum B, Mossmann H, Domdey H, von Specht B. TH1 cells trigger tumor necrosis factor alpha-mediated hypersensitivity to Pseudomonas aeruginosa after adoptive transfer into SCID mice. Infect Immun. 1995;63:1107-12 pubmed